Skip to content

ChiCTR2300068001A multicenter randomized controlled trial of functional dyspepsia treated with acupuncture related to meridians and viscera

ChiCTR2300068001A multicenter randomized controlled trial of functional dyspepsia treated with acupuncture related to meridians and viscera

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068001
Enrollment
Unknown
Registered
2023-02-02
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Dyspepsia

Interventions

Drug group:Oral lansoprazole
wait-and-see group:No intervention

Sponsors

The Second Affiliated Hospital of Hunan University of Chinese Medicine/Hunan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Meet the western diagnostic criteria for functional dyspepsia; 2. 18-70 years old; 3. No organic lesions were found by gastroscopy and B-ultrasound; 4. Voluntarily sign informed consent; 5. Patients with good compliance.

Exclusion criteria

Exclusion criteria: 1. Drugs that affect gastrointestinal motility or gastric acid secretion or other functional dyspepsia related interventions have been taken or are being taken in the last 2 weeks; 2. Those who have received acupuncture treatment in the last 14 days; 3. Complicated with other gastrointestinal diseases; 4. Pregnant or breast-feeding women or pregnant women; 5. Patients with serious heart, lung, liver, spleen, kidney and blood diseases, serious history of endocrine and metabolic diseases, cardiovascular and cerebrovascular diseases, autoimmune diseases and malignant tumors; 6. Persons with severe mental and psychological disorders (SAS <= 50, SDS <= 50).

Design outcomes

Primary

MeasureTime frame
Symptom resolution rate;Nipin Dyspepsia Index Short Form (SF-NDI) after 4 weeks;

Secondary

MeasureTime frame
Upper Gastrointestinal Symptom Severity Scale (PAGI-SYM) score;Nipin Dyspepsia Index Short Form (SF-NDI);Leeds Dyspepsia Questionnaire (LDQ);Functional Dyspepsia Quality of Life Scale (FDDQL);SF - 36 scale;Hamilton Anxiety Inventory (HAMA);Hamilton Depression Scale (HAMD);Hospital Depression and Anxiety Scale (HADS);Motilin (MTL);5-hydroxytryptamine (5-HT);Somatostatin (SS);Substance P (SP);Ghrelin;

Countries

China

Contacts

Public ContactWeiai Liu/Mi Liu

The Second Affiliated Hospital of Hu'nan University of Chinese Medicine/Hu'nan University of Chinese Medicine

55999630@qq.com+86 13787016026/+86 15116387811

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026